The Role of JAK2 Inhibition in Polycythemia Vera

Two experts discuss the use of JAK2 inhibition in diagnosing, treating, and managing polycythemia vera, including risk stratification, traditional cytoreductive therapies vs JAK2 inhibitor therapy, and investigational agents.

 Targeted Oncology

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.